
BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260801
DTEND;VALUE=DATE:20260806
DTSTAMP:20260727T120147Z
CREATED:20260727T120147Z
LAST-MODIFIED:20260727T120147Z
UID:10000834-1785542400-1785974399@oncodaily.com
SUMMARY:CGC 2026 Annual Meeting
DESCRIPTION:The 17th Annual Meeting of the Cancer Genomics Consortium\, organized by the Cancer Genomics Consortium (CGC)\, will take place on 1–5 August 2026 at The Royal Sonesta Houston Galleria in Houston\, Texas\, with both in-person and online participation available. \nThe meeting will focus on the latest scientific\, technological\, and clinical advances in cancer genomics and their application to patient care. The programme will begin with an Unconference\, followed by keynote lectures\, invited scientific sessions\, case-study presentations\, platform abstracts\, posters\, and round-table discussions. \nDedicated networking activities will include an early-career reception\, industry engagement\, and optional social events. Reduced registration fees will also be available to support participation from resource-limited countries. \nRegister Now.
URL:https://oncodaily.com/event/cgc-2026-552372
LOCATION:The Royal Sonesta Houston Galleria\, 2222 West Loop South\, Houston\, TX\, 77027\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-27-2026-03_56_51-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260803
DTEND;VALUE=DATE:20261013
DTSTAMP:20260720T142608Z
CREATED:20260720T142239Z
LAST-MODIFIED:20260720T142608Z
UID:10000802-1785715200-1791849599@oncodaily.com
SUMMARY:ESMO Academy 2026
DESCRIPTION:The ESMO Academy 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place virtually from 3 August to 12 October 2026. \nThe programme will combine on-demand educational modules with live interactive sessions led by ESMO faculty\, covering major tumour types\, clinical trial methodology\, treatment principles\, pharmacokinetics\, drug interactions\, and topics relevant to the ESMO Examination. Access is initially limited to participants registered for the ESMO Examination 2026\, while the modules will become available to all ESMO members from November 2026. Registered participants will receive access details closer to the course start date.
URL:https://oncodaily.com/event/esmo-academy-2026-546719
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-20-2026-06_21_08-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260807
DTEND;VALUE=DATE:20260809
DTSTAMP:20260614T151721Z
CREATED:20260614T151721Z
LAST-MODIFIED:20260614T151721Z
UID:10000761-1786060800-1786233599@oncodaily.com
SUMMARY:2026 Summit for Novel Therapeutics in Oncology and Precision Medicine in Cancer (STOP Cancer)
DESCRIPTION:The 2026 Summit for Novel Therapeutics in Oncology and Precision Medicine in Cancer (STOP Cancer) will bring together many of the world’s leading oncology researchers\, physician-scientists\, and clinical innovators on August 7-8\, 2026\, at the New York Marriott Marquis in Times Square. \nThe multidisciplinary conference is designed to bridge groundbreaking translational research with real-world patient care\, highlighting the latest advances in precision medicine\, targeted therapies\, antibody-drug conjugates (ADCs)\, biomarker-driven treatment strategies\, immunotherapy\, radiopharmaceuticals\, and early-phase clinical trials. The program will feature nationally recognized experts from leading institutions including Memorial Sloan Kettering Cancer Center\, Stanford Cancer Institute\, Mayo Clinic\, Dana-Farber Cancer Institute\, Vanderbilt University Medical Center\, MD Anderson Cancer Center\, and NEXT Oncology. \nAmong the distinguished faculty is Dr. Sarat Chandarlapaty of Memorial Sloan Kettering Cancer Center\, who will deliver the prestigious Daniel D. Von Hoff Keynote Lecture. Dr. Chandarlapaty is internationally recognized for his contributions to breast cancer research and precision oncology. \nThe summit also features an exceptional lineup of speakers who are helping define the future of cancer therapeutics\, including: \n• Dr. Vivek Subbiah\, Stanford Cancer Institute\, a globally recognized leader in drug development and precision oncology\, presenting on the evolution and future of tumor-agnostic therapies. \n• Dr. Eileen M. O’Reilly\, Memorial Sloan Kettering Cancer Center\, one of the nation’s foremost experts in gastrointestinal malignancies\, discussing recent precision medicine advances in GI cancers. \n• Dr. Alexander I. Spira\, Chief Scientific Officer of NEXT Oncology\, presenting emerging developments in RAS-targeted therapies and next-generation oncology drug development. \n• Dr. Anthony W. Tolcher\, Founder and CEO of NEXT Oncology and a pioneer in early-phase clinical trials\, discussing innovative approaches including RAS PROTACs and molecular glues. \n• Dr. Cathy Eng\, Vanderbilt University Medical Center and Co-Chair of the National Cancer Institute Gastrointestinal Steering Committee\, presenting on ctDNA applications and biomarker-driven management strategies in colorectal cancer. \n• Dr. Vamsi Velcheti\, Mayo Clinic\, an internationally recognized thoracic oncologist and cancer researcher\, discussing the development of antibody-drug conjugates in lung cancer. \n• Dr. Guru P. Sonpavde\, AdventHealth Cancer Institute\, a leading investigator in genitourinary oncology and phase I clinical research\, presenting on ADC innovation in GU malignancies. \n• Dr. Eytan Stein\, Memorial Sloan Kettering Cancer Center\, one of the nation’s leading leukemia drug development experts\, discussing precision medicine advances in myeloproliferative neoplasms. \n• Dr. Ghassan K. Abou-Alfa\, Memorial Sloan Kettering Cancer Center\, a globally respected authority in hepatobiliary cancers\, presenting emerging innovations in HER2-targeted therapy. \n• Dr. Ulka Vaishampayan\, University of Michigan Rogel Cancer Center\, discussing advances in alpha-emitter radiopharmaceutical therapies for prostate cancer. \nAdditional presentations will explore emerging TP53-targeted therapies\, PRMT5 inhibitors\, novel biomarker methodologies\, digital biomarkers\, clinical trial innovation\, patient-reported outcomes\, decentralized clinical trials\, and next-generation immunotherapy approaches. \n“The pace of innovation in oncology has never been greater\,” said Dr. Hani Babiker\, Course Director and Associate Professor of Medicine at Mayo Clinic. “STOP Cancer was created to provide a forum where clinicians\, researchers\, and healthcare professionals can engage directly with leaders developing the therapies and technologies that will shape the future of cancer care.” \nThe conference is intended for medical oncologists\, hematologists\, radiation oncologists\, surgical oncologists\, advanced practice providers\, pharmacists\, nurses\, fellows\, researchers\, and other healthcare professionals involved in cancer care. \nRegister now.
URL:https://oncodaily.com/event/precision-medicine-520908
LOCATION:New York Marriott Marquis\, 1535 Broadway\, New York\, NY\, 10036\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/Annotation-2026-06-14-191317.webp
ORGANIZER;CN="Horizon CME":MAILTO:info@horizoncme.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260807
DTEND;VALUE=DATE:20260809
DTSTAMP:20260803T193143Z
CREATED:20260803T193129Z
LAST-MODIFIED:20260803T193143Z
UID:10000857-1786060800-1786233599@oncodaily.com
SUMMARY:APP Cancer Research Summit 2026
DESCRIPTION:The APP Cancer Research Summit 2026\, presented by the Advanced Practice Providers Oncology Summit (APPOS)\, will take place on 7–8 August 2026 at the New York Marriott Marquis in New York City. \nDesigned specifically for advanced practice providers working across the oncology research continuum\, the two-day conference will cover clinical-trial fundamentals\, developing and leading independent research\, expanding the APP’s role within research teams\, and emerging trends in oncology research. The Summit will be held alongside the Summit for Novel Therapeutics in Oncology & Precision Medicine in Cancer (STOP Cancer)\, providing additional opportunities for education\, collaboration\, and networking.
URL:https://oncodaily.com/event/app-cancer-research-558653
LOCATION:New York Marriott Marquis\, 1535 Broadway\, New York\, NY\, 10036\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ACRS_logo_16x9_exact.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260807T170000
DTEND;TZID=America/Halifax:20260807T180000
DTSTAMP:20260805T222206Z
CREATED:20260805T222206Z
LAST-MODIFIED:20260805T222206Z
UID:10000869-1786122000-1786125600@oncodaily.com
SUMMARY:Updates in Chronic Myeloid Leukemia in Adults and Children – Resonance
DESCRIPTION:The ALRCaN Global webinar\, “Updates in Chronic Myeloid Leukemia in Adults and Children\,” is scheduled for Friday\, August 7\, 2026\, from 9:00 AM to 10:00 AM ET (5:00 PM to 6:00 PM AMT). \nPresented by Scott Howard and organized by the Acute Leukemia Research and Care Network (ALRCaN)\, the webinar is part of the network’s weekly educational series featuring discussions on leukemia and supportive care topics. The series is supported by Scott Howard\, Stacy Cooper\, Archie Bleyer\, Dan Douer\, and the Resonance Team.
URL:https://oncodaily.com/event/chronic-myeloid-leukemia-559863
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/IMG_2408.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260811
DTEND;VALUE=DATE:20260812
DTSTAMP:20260803T194555Z
CREATED:20260803T194555Z
LAST-MODIFIED:20260803T194555Z
UID:10000858-1786406400-1786492799@oncodaily.com
SUMMARY:APPOS 2026: Advances in CAR T-Cell Therapy and Toxicity Management
DESCRIPTION:The networking CE dinner “CAR T-Cell Therapy in 2026: Advances in Safety\, Efficacy\, and Toxicity Management”\, presented by the Advanced Practice Providers Oncology Summit (APPOS)\, will take place on 11 August 2026 at Nick + Stef’s Steakhouse in Los Angeles\, California. \nThe two-hour educational programme will review CAR T-cell mechanisms\, recent strategies for reducing treatment-related toxicity\, efficacy data for FDA-approved therapies across hematologic malignancies\, and the recognition and management of established and emerging adverse effects. The event is primarily intended for nurse practitioners\, physician assistants\, pharmacists\, and nurses\, while physicians\, students\, and other healthcare professionals involved in oncology care are also welcome. Participants may earn continuing education credits and network with colleagues during the dinner.
URL:https://oncodaily.com/event/appos-558682
LOCATION:Nick + Stef’s Steakhouse\, 330 South Hope Street\, Los Angeles\, CA\, 90071\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-3-2026-11_45_16-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260812
DTEND;VALUE=DATE:20260814
DTSTAMP:20260113T235414Z
CREATED:20260113T235354Z
LAST-MODIFIED:20260113T235414Z
UID:10000570-1786492800-1786665599@oncodaily.com
SUMMARY:NCODA Oncology Institute
DESCRIPTION:The NCODA Oncology Institute is an annual event that brings together healthcare providers and industry leaders to improve patient access and optimize oncology care delivery. \nThe 2026 meeting is scheduled for August 12–13\, 2026\, in Atlanta\, Georgia. It focuses on strengthening industry-practice partnerships and developing forward-thinking strategies to ensure timely medication delivery for cancer patients.
URL:https://oncodaily.com/event/ncoda-oncology-institute-440723
LOCATION:Omni Atlanta Hotel at Centennial Park\, 190 Marietta St NW\, Atlanta\, GA\, 30303\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/NCODA-Oncology-Institute.webp
ORGANIZER;CN="NCODA":MAILTO:contact@ncoda.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260813
DTEND;VALUE=DATE:20260816
DTSTAMP:20260720T112913Z
CREATED:20260720T112913Z
LAST-MODIFIED:20260720T112913Z
UID:10000798-1786579200-1786838399@oncodaily.com
SUMMARY:2026 SNO/ASCO CNS Metastases Conference
DESCRIPTION:The 2026 SNO/ASCO CNS Metastases Conference\, organized by the Society for Neuro-Oncology (SNO) in collaboration with the American Society of Clinical Oncology (ASCO)\, will take place on 13–15 August 2026 at the Westin Copley Place in Boston\, Massachusetts. \nUnder the theme “From Moonshot to Groundshot: Transforming Science into Impact\,” the interdisciplinary programme will connect scientific discovery with clinical care across brain and leptomeningeal metastases. Key topics include CNS-active targeted therapies and immunotherapies\, precision neurosurgery\, stereotactic and FLASH radiotherapy\, device-based treatments\, toxicity management\, survivorship\, quality of life\, and data-driven decision-making. The event will also feature oral abstract presentations\, a poster networking reception\, and a complimentary workshop for early-career professionals and young investigators. Keynote speakers include Lizza Hendriks and Benjamin Izar. \nConference Registration.
URL:https://oncodaily.com/event/546557
LOCATION:The Westin Copley Place\, 10 Huntington Avenue\, Boston\, MA\, 02116\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-20-2026-03_17_19-PM.webp
ORGANIZER;CN="Society for Neuro-Oncology":MAILTO:melesa@soc-neuro-onc.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260813
DTEND;VALUE=DATE:20260816
DTSTAMP:20260805T221929Z
CREATED:20260805T221929Z
LAST-MODIFIED:20260805T221929Z
UID:10000870-1786579200-1786838399@oncodaily.com
SUMMARY:The 26th Asia-Pacific Prostate Cancer Conference - APCC 2026
DESCRIPTION:The 26th Asia-Pacific Prostate Cancer Conference (APCC 2026)\, hosted by the Australian Prostate Centre\, will take place on 13–15 August 2026 at the Melbourne Convention and Exhibition Centre in Melbourne\, Australia. \nThe multidisciplinary programme will bring together clinicians\, researchers\, nurses\, and allied health professionals to examine next-generation targeted therapies\, metastasis-directed treatment\, PSMA imaging and radionuclide therapy\, treatment intensification and sequencing\, immunotherapy\, artificial intelligence\, genomics\, survivorship\, sexual rehabilitation\, and health equity. \nGetz Healthcare will participate as an exhibitor at Booth 14\, presenting the NanoKnife System and TULSA-PRO System as examples of targeted ablation technologies used in prostate cancer care.
URL:https://oncodaily.com/event/prostate-cancer-560494
LOCATION:Melbourne Convention and Exhibition Centre (MCEC)\, 1 Convention Centre Place\, South Wharf\, Melbourne\, Victoria\, 3006\, Australia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/apcc-2026-landscape.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260813
DTEND;VALUE=DATE:20260817
DTSTAMP:20260730T165005Z
CREATED:20260730T165005Z
LAST-MODIFIED:20260730T165005Z
UID:10000845-1786579200-1786924799@oncodaily.com
SUMMARY:29th Annual Oncology Symposium for the Healthcare
DESCRIPTION:The 29th Annual Oncology Symposium for the Healthcare Provider\, organized by the Association of PAs in Oncology (APAO)\, will take place on 13–16 August 2026 at the New York Marriott Marquis in New York City. \nDesigned for oncology healthcare professionals\, the symposium will feature expert-led education\, practical discussions\, and updates across hematology and oncology\, radiation oncology\, and palliative and supportive care. Participants will be able to explore current best practices\, discover innovative approaches that can be incorporated into clinical practice\, connect with colleagues and industry experts\, and learn about emerging technologies and solutions from exhibitors and sponsors. APAO is the national professional organization representing physician associates working across oncology disciplines. \nRegister Today.
URL:https://oncodaily.com/event/oncology-symposium-for-the-healthcare-555266
LOCATION:New York Marriott Marquis\, 1535 Broadway\, New York\, NY\, 10036\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/association-of-physician-assistants-in-oncology-save-the-date-annual-oncology-symposium-new-york-city-august-2026-rectangle.webp
ORGANIZER;CN="Association of PAs in Oncology (APAO)":MAILTO:admin@apao.cc
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260814
DTEND;VALUE=DATE:20260816
DTSTAMP:20260725T215225Z
CREATED:20260725T215225Z
LAST-MODIFIED:20260725T215225Z
UID:10000832-1786665600-1786838399@oncodaily.com
SUMMARY:Louisiana Oncology Society 2026 Cancer Congress
DESCRIPTION:The LOS 2026 Cancer Congress: National Oncology Updates\, organized by the Louisiana Oncology Society (LOS)\, will take place on 14–15 August 2026 at the New Orleans Marriott Warehouse Arts District in New Orleans\, Louisiana. \nThe in-person congress will bring together oncology professionals from across the state to examine national and regional developments affecting cancer care\, including healthcare disparities\, emerging therapies\, treatment advances\, and challenges in oncology practice management. Through expert-led discussions and professional networking\, attendees will gain practical strategies to improve care delivery and patient outcomes while strengthening collaboration within Louisiana’s oncology community. \n 
URL:https://oncodaily.com/event/louisiana-oncology-society-2026-551036
LOCATION:New Orleans Marriott Warehouse Arts District\, 859 Convention Center Boulevard\, New Orleans\, 70130\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-26-2026-01_51_03-AM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260814T150000
DTEND;TZID=America/Halifax:20260814T170000
DTSTAMP:20260814T161017Z
CREATED:20260814T160906Z
LAST-MODIFIED:20260814T161017Z
UID:10000912-1786719600-1786726800@oncodaily.com
SUMMARY:The Evidence Synthesis Seminar Series: How to Critically Appraise a Case-Control Study
DESCRIPTION:The Evidence Synthesis Seminar Series: How to Critically Appraise a Case-Control Study\, jointly organized by NCODA\, the Faculty of Medical Sciences at Mohammed VI Polytechnic University (UM6P)\, and AORTIC\, will take place online on 14 August 2026\, from 15:00 to 17:00 GMT+1.  \nThe complimentary session will be presented by Nasser Laouali\, PhD\, from the Faculty of Medical Sciences at UM6P in Morocco\, and is designed for healthcare professionals\, biomedical and clinical researchers\, and students interested in strengthening their skills in evidence synthesis and critical appraisal. The session will focus specifically on the principles and practical considerations involved in critically appraising case-control studies. \nRegister.
URL:https://oncodaily.com/event/evidence-synthesis-seminar-566363
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-14-2026-08_03_15-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260814T170000
DTEND;TZID=America/Halifax:20260814T180000
DTSTAMP:20260813T173151Z
CREATED:20260813T173151Z
LAST-MODIFIED:20260813T173151Z
UID:10000909-1786726800-1786730400@oncodaily.com
SUMMARY:Germline Predisposition and Acute Leukemia - Resonance
DESCRIPTION:The ALRCaN Global webinar\, “Germline Predisposition and Acute Leukemia\,” is scheduled for Friday\, August 14\, 2026\, from 9:00 AM to 10:00 AM ET (5:00 PM to 6:00 PM AMT). \nPresented by Anna Avagyan and organized by the Acute Leukemia Research and Care Network (ALRCaN)\, the webinar is part of the network’s weekly educational series featuring discussions on leukemia and supportive care topics. The series is supported by Scott Howard\, Stacy Cooper\, Archie Bleyer\, Dan Douer\, and the Resonance Team.
URL:https://oncodaily.com/event/germline-predisposition-565331
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/daa7bcc676908e9db22a7007c03a5dd5_exif.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260817
DTEND;VALUE=DATE:20260819
DTSTAMP:20260803T201402Z
CREATED:20260803T201246Z
LAST-MODIFIED:20260803T201402Z
UID:10000860-1786924800-1787097599@oncodaily.com
SUMMARY:2026 Hereditary Cancer Genetics: Incorporation into Clinical Care
DESCRIPTION:The 2026 Hereditary Cancer Genetics: Incorporation into Clinical Care conference\, hosted by Memorial Sloan Kettering Cancer Center (MSK)\, will take place on 17–18 September 2026 at the Zuckerman Research Center in New York City\, with both in-person and virtual attendance available. \nThe two-day programme will provide practical training in hereditary cancer genetics\, covering breast\, gynecologic\, gastrointestinal\, genitourinary\, pediatric\, and hematologic malignancies\, rare cancer syndromes\, genetic test interpretation\, surveillance\, risk reduction\, tumor profiling\, precision oncology\, early detection\, and prevention. The conference is designed for oncologists\, genetic counselors\, advanced practice providers\, nurses\, and other healthcare professionals and will include expert lectures\, multidisciplinary panels\, case-based sessions\, and networking. \nRegistration costs $300 for physicians\, $200 for advanced practice providers and genetic counselors\, $150 for trainees\, nurses\, and other healthcare professionals\, and $525 for industry professionals; MSK employees may attend free of charge.
URL:https://oncodaily.com/event/hereditary-cancer-genetics-558718
LOCATION:Mortimer B. Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-4-2026-12_11_20-AM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260819T140000
DTEND;TZID=America/Halifax:20260819T150000
DTSTAMP:20260816T162439Z
CREATED:20260816T162439Z
LAST-MODIFIED:20260816T162439Z
UID:10000921-1787148000-1787151600@oncodaily.com
SUMMARY:NCI The Genomic\, Host\, and Microenvironmental Determinants of Cancer Progression Webinar
DESCRIPTION:The Genomic\, Host\, and Microenvironmental Determinants of Cancer Progression webinar\, hosted by the National Cancer Institute (NCI)\, will take place virtually on 19 August 2026\, from 2:00 PM to 3:00 PM ET. \nThe session will feature Christina Curtis\, PhD\, MSc\, Professor of Medicine\, Genetics\, and Biomedical Data Science at Stanford University\, with Rao Divi\, PhD\, MSc\, Program Director in the Environmental Epidemiology Branch of NCI’s Epidemiology and Genomics Research Program\, serving as moderator. \nThe webinar will explore how tumor genomics\, inherited germline variation\, host immunity\, and the tumor microenvironment influence cancer progression and clinical outcomes. Topics will include long-term prediction of breast cancer recurrence using somatic copy-number alterations\, the role of Germline Epitope Burden (GEB) in immune recognition and tumor evolution\, and emerging approaches for studying premalignancy using CRISPR/Cas9-engineered organoids and high-resolution human tissue profiling. \nThe meeting will be held online and is intended for researchers and healthcare professionals interested in cancer genomics\, tumor evolution\, immunology\, and precision oncology.
URL:https://oncodaily.com/event/cancer-progression-webinar-567882
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/nci-logo-1.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260821T170000
DTEND;TZID=America/Halifax:20260821T180000
DTSTAMP:20260819T132518Z
CREATED:20260819T132505Z
LAST-MODIFIED:20260819T132518Z
UID:10000929-1787331600-1787335200@oncodaily.com
SUMMARY:Gene Regulation of Latino-Associated B-ALL SNPs and CAR-T Resistance in Heme Malignancies - Resonance
DESCRIPTION:The ALRCaN Global webinar\, “Gene Regulation of Latino-Associated B-ALL SNPs & CAR-T Resistance in Heme Malignancies\,” is scheduled for Friday\, August 21\, 2026\, from 9:00 AM to 10:00 AM ET (5:00 PM to 6:00 PM AMT). \nPresented by Clarissa Garcia and Isaac Vigil and organized by the Acute Leukemia Research and Care Network (ALRCaN)\, the webinar is part of the network’s weekly educational series featuring discussions on leukemia and supportive care topics. The series is supported by Scott Howard\, Stacy Cooper\, Archie Bleyer\, Dan Douer\, and the Resonance Team.
URL:https://oncodaily.com/event/gene-regulation-569117
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/Hana-5.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260822T063000
DTEND;TZID=America/Halifax:20260822T063000
DTSTAMP:20260725T145953Z
CREATED:20260725T145953Z
LAST-MODIFIED:20260725T145953Z
UID:10000830-1787380200-1787380200@oncodaily.com
SUMMARY:IOS 2026 Best of ASCO
DESCRIPTION:The IOS 2026 Best of ASCO\, organized by the Iowa Oncology Society (IOS) in conjunction with the Holden Comprehensive Cancer Center\, will take place in person on 22 August 2026\, beginning at 6:30 a.m. CDT\, at the Hyatt Regency Coralville Hotel & Conference Center in Coralville\, Iowa. \nThe meeting will bring together oncology professionals from across the region to review practice-changing research and major clinical updates presented at the 2026 ASCO Annual Meeting. Through expert-led sessions and professional networking\, participants will gain insights that can be applied to everyday cancer care and connect with colleagues working across the oncology community.
URL:https://oncodaily.com/event/ios-550974
LOCATION:Hyatt Regency Coralville Hotel & Conference Center\, 300 East 9th Street\, Coralville\, IA\, 52241\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-25-2026-06_58_55-PM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260823
DTEND;VALUE=DATE:20260824
DTSTAMP:20251216T230843Z
CREATED:20251216T230843Z
LAST-MODIFIED:20251216T230843Z
UID:10000502-1787443200-1787529599@oncodaily.com
SUMMARY:7th Global Cancer Summit (GCS 2026)
DESCRIPTION:The 7th Global Cancer Summit (GCS 2026)\, themed “Living with Cancer in the 21st Century\,” is scheduled for August 23\, 2026\, at the Swatantrata Bhawan Auditorium\, Banaras Hindu University (BHU) in Varanasi\, Uttar Pradesh\, India. \nOrganized by the BioGenesis Health Cluster and the Global Cancer Foundation\, this summit focuses on the global burden of cancer\, with a special emphasis on women’s cancers. The scientific program aims to bring together international experts through plenary sessions\, live workshops on topics like breast and cervical cancer\, and interactive discussions to devise strategies against the disease. \nRegister.
URL:https://oncodaily.com/event/global-cancer-summit-429662
LOCATION:Swatantrata Bhawan Auditorium\, Banaras Hindu University (BHU)\, Lanka\, BHU Campus\, Varanasi\, Uttar Pradesh\, 221005\, India
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/GCS-2026.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260824
DTEND;VALUE=DATE:20260829
DTSTAMP:20260702T101909Z
CREATED:20260702T101909Z
LAST-MODIFIED:20260702T101909Z
UID:10000781-1787529600-1787961599@oncodaily.com
SUMMARY:ESO-ESSO-ESTRO-ESP Multidisciplinary Course on Oncology for Medical Students
DESCRIPTION:The ESO-ESSO-ESTRO-ESP Multidisciplinary Course in Oncology for Medical Students takes place 24–28 August 2026 at Johannes Kepler University\, Linz\, Austria.  \nJointly organised by ESO\, ESSO\, ESTRO and ESP\, the course is designed to encourage medical students to specialise in an oncology-related discipline. Open to students who have completed their fourth year of studies\, participation is limited to 40 selected candidates. \nOver one intensive week\, the programme combines theoretical plenary sessions\, MDT case presentations\, clinical visits in small groups\, and pre-recorded lectures\, with a focus on gastrointestinal\, breast\, lung\, gynaecologic\, and genitourinary cancers. \nParticipants will also prepare and deliver a group presentation on the final day. By the end of the course\, students will have a comprehensive understanding of all aspects of oncology and the multidisciplinary approach to cancer treatment.
URL:https://oncodaily.com/event/oncology-533343
LOCATION:Johannes Kepler University\, Krankenhausstraße 5\, LEH-Gebäude 4\, Linz\, 4020\, Austria
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/e7d9b088a9ea44fab164b6aba3360560.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260826
DTEND;VALUE=DATE:20260830
DTSTAMP:20260327T121947Z
CREATED:20260327T121841Z
LAST-MODIFIED:20260327T121947Z
UID:10000712-1787702400-1788047999@oncodaily.com
SUMMARY:8th World Congress of the International Federation of Head and Neck Oncologic Societies (IFHNOS 2026)
DESCRIPTION:The 8th IFHNOS World Congress will be held from Wednesday\, August 26\, to Saturday\, August 29\, 2026\, at the Brisbane Convention and Exhibition Centre in Queensland\, Australia. \nCentered on the theme “Global Harmonization of Head and Neck Cancer Care through international collaboration\,” this summit is co-organized by the International Federation of Head and Neck Oncologic Societies (IFHNOS) and the Australian and New Zealand Head and Neck Cancer Society (ANZHNCS). Bringing together experts from over 70 member societies across 58 countries\, the congress features a high-density scientific program focused on multidisciplinary care\, surgical innovation\, and global health equity in head and neck oncology. \nRegister now.
URL:https://oncodaily.com/event/ifhnos-475611
LOCATION:Brisbane Convention and Exhibition Centre\, Grey St\, South Brisbane\, Queensland\, 4101\, Australia
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/BeFunky-collage-2026-03-27T162038.729.webp
ORGANIZER;CN="International Federation of Head and Neck Oncologic Societies (IFHNOS)":MAILTO:info@ifhnos.net
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260827
DTEND;VALUE=DATE:20260831
DTSTAMP:20260715T162507Z
CREATED:20260715T161840Z
LAST-MODIFIED:20260715T162507Z
UID:10000789-1787788800-1788134399@oncodaily.com
SUMMARY:International Society for Experimental Hematology (ISEH) 55th Annual Scientific Meeting
DESCRIPTION:The International Society for Experimental Hematology (ISEH) will host its 55th Annual Scientific Meeting from 27–30 August 2026 at Goethe University Frankfurt\, Campus Westend in Frankfurt\, Germany. ISEH is a global organization of over 650 members focused on connecting experimental hematologists to advance research\, develop novel therapies and diagnostic tools\, and strengthen the global scientific network\, with content spanning basic and translational research\, clinical trials in hematology\, hemato-oncology\, stem cell research\, immuno-oncology\, and cellular therapy. \nAhead of the main program\, the meeting features three workshops and symposia: \n\nSymposium on Translational Hematology: Towards Chemo-Free Therapy in Hematologic Malignancies (Thursday\, 27 August\, free)\nNew Investigators Workshop\, a trainee-focused pre-meeting workshop for graduate students\, PhD/MD candidates\, and postdocs (Thursday\, 27 August\, $90 USD)\n2026 Symposium on “Human Pluripotent Stem Cell-Derived Hematopoiesis“ (iPSC Symposium\, an independently organized affiliated event).\n\nKey deadlines: \n\n4 February: Call for Abstracts Opens\n12 March: Registration Opens\n17 April: Call for Abstracts Submission Final Deadline\, No Extensions\n26 May: Call for Abstracts Late-Breaking Call for Abstracts Opens\n19 June: Late-Breaking Call for Abstracts Submission Final Deadline\, No Extensions\n16 July: Early Registration Pricing Ends
URL:https://oncodaily.com/event/iseh-542968
LOCATION:Goethe University Frankfurt\, Campus Westend\, Hörsaalzentrum\, Theodor-W.-Adorno-Platz 5\, 60323\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/761a859ff45d4580ba87f9fdcaeec11b.webp
ORGANIZER;CN="International Society for Experimental Hematology (ISEH)":MAILTO:info@iseh.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260827T110000
DTEND;TZID=America/Halifax:20260827T120000
DTSTAMP:20260817T155152Z
CREATED:20260817T155152Z
LAST-MODIFIED:20260817T155152Z
UID:10000926-1787828400-1787832000@oncodaily.com
SUMMARY:The CAN Monthly Membership Meeting Call
DESCRIPTION:The CAN Monthly Membership Meeting Call\, organized by the Community Oncology Alliance Administrators’ Network (CAN)\, will take place on August 27\, 2026\, from 11:00 AM to 12:00 PM. The monthly call is intended for CAN members and provides a forum for community oncology practice administrators and management team members to discuss issues affecting practice operations\, share experiences and best practices\, and connect with peers across the community oncology network. Discussion topics vary from meeting to meeting.
URL:https://oncodaily.com/event/can-monthly-membership-568512
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/1759242506358_myCOA-banner-CAN-membershipcalls.webp
ORGANIZER;CN="Community Oncology Alliance Administrators%E2%80%99 Network (CAN)":MAILTO:info@coacancer.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260827T180000
DTEND;TZID=America/Halifax:20260827T190000
DTSTAMP:20260814T151453Z
CREATED:20260814T151453Z
LAST-MODIFIED:20260814T151453Z
UID:10000911-1787853600-1787857200@oncodaily.com
SUMMARY:The AORTICHORG 3rd Quarterly Webinar
DESCRIPTION:The AORTICHORG 3rd Quarterly Webinar\, organized by the African Organisation for Research and Training in Cancer (AORTIC) through its AORTIC Hematology Oncology Research Group (AORTICHORG)\, will take place virtually on 27 August 2026\, from 6:00 PM to 7:00 PM SAST. \nThe webinar is part of AORTICHORG’s quarterly educational series\, bringing together professionals involved in hematology and oncology for online scientific exchange\, discussion\, and collaboration. The session will be delivered online via Zoom\, allowing participants to join remotely. The official event page currently confirms the date\, time\, virtual format\, and organizer but does not provide a specific scientific topic\, speaker list\, or detailed agenda for this webinar.
URL:https://oncodaily.com/event/aortichorg-566343
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2024/10/IMG_6337-e1742111008423.jpeg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260828
DTEND;VALUE=DATE:20260831
DTSTAMP:20260121T222018Z
CREATED:20260121T222011Z
LAST-MODIFIED:20260121T222018Z
UID:10000609-1787875200-1788134399@oncodaily.com
SUMMARY:ESTRO Meets Asia 2026
DESCRIPTION:The ESTRO Meets Asia 2026 is a collaborative scientific event scheduled for August 28–30\, 2026\, in Singapore. This joint venture between the European SocieTy for Radiotherapy and Oncology (ESTRO) and The Federation of Asian Organizations for Radiation Oncology (FARO) aims to foster international collaboration and share advancements in science\, education\, and technology for the benefit of patients. \nThe comprehensive program is structured into three distinct components—a Clinical Practice track\, an Innovation track\, and an Education track—designed to address the interests of all radiotherapy disciplines. In addition to expert-led sessions and a large industry exhibition showcasing the latest developments in oncology\, the congress invites researchers to submit abstracts between February 2 and March 11\, 2026\, with top submissions potentially featured in ESTRO journals and virtual special issues.
URL:https://oncodaily.com/event/estro-meets-asia-444831
LOCATION:Singapore Expo\, 1 Expo Drive\, Singapore\, Tampines\, 486150\, Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/01/EMA2026.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260828
DTEND;VALUE=DATE:20260831
DTSTAMP:20260801T115916Z
CREATED:20260701T124240Z
LAST-MODIFIED:20260801T115916Z
UID:10000779-1787875200-1788134399@oncodaily.com
SUMMARY:Community Oncology Global Congress 2026
DESCRIPTION:The Community Oncology Global Congress 2026 is an international virtual congress taking place 28–30 August 2026\, dedicated to advancing cancer care in community settings around the world. Through expert-led sessions\, regional perspectives\, and multidisciplinary discussions\, the programme will explore how community-based cancer care can be strengthened across diverse healthcare environments — from access to timely diagnosis and treatment delivery to survivorship support\, palliative care\, and the use of digital tools. \nScientific leadership includes Jasmine Kamboj (Mayo Clinic)\, Foluke Sarimiye (The Onco Clinic)\, Felipe Roitberg (Brazil)\, Debra Patt (Texas Oncology)\, Joanna Metzner-Sadurski (USA) and Kashyap Patel (Community Oncology Alliance)\, with many speakers from across the globe. \nBy bringing together experts from different countries and healthcare systems\, the congress aims to encourage meaningful dialogue and support the development of adaptable solutions that can improve cancer care in community settings worldwide. \nRegister now.
URL:https://oncodaily.com/event/community-oncology-global-congress-532726
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/IMG_8507.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260901
DTEND;VALUE=DATE:20260904
DTSTAMP:20260222T121336Z
CREATED:20260222T121336Z
LAST-MODIFIED:20260222T121336Z
UID:10000661-1788220800-1788479999@oncodaily.com
SUMMARY:Cancer Grand Challenges Conference - Spatial Biology
DESCRIPTION:The Spatial Biology 2026 conference\, part of the prestigious Cancer Grand Challenges series\, is set to take place from September 1–3 at The Royal Society in London.  \nChaired by Professor Greg Hannon (CRUK Cambridge Institute)\, this landmark summit convenes global pioneers to explore the “inflection point” of spatial omics and 3D tumor mapping. Building on the legacy of the IMAXT and Rosetta grand challenge teams\, the program will delve into AI-driven data integration\, multidimensional tumor heterogeneity\, and the transition of spatial tools from descriptive research to clinical diagnostic applications. With an elite speaker faculty including Dana Pe’er (Sloan Kettering)\, Fei Chen (Broad Institute)\, and Bernd Bodenmiller (UZH)\, the event serves as a critical forum for oncologists\, technology developers\, and policymakers to define the future of precision medicine through the lens of the tumor microenvironment. \nRegistration is now open and will close on Monday 13 July 2026. If you’re interested in attending\, register here.
URL:https://oncodaily.com/event/cancer-grand-challenges-459490
LOCATION:The Royal Society\, 6-9 Carlton House Terrace\, London\, Greater London\, SW1Y 5AG\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-22T161329.801.webp
ORGANIZER;CN="Cancer Grand Challenges":MAILTO:info@cancergrandchallenges.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260902
DTEND;VALUE=DATE:20260905
DTSTAMP:20260315T135543Z
CREATED:20260315T135543Z
LAST-MODIFIED:20260315T135543Z
UID:10000696-1788307200-1788566399@oncodaily.com
SUMMARY:Korean Society of Medical Oncology (KSMO) 2026 Annual Meeting
DESCRIPTION:The KSMO 2026 Annual Meeting—marking the 19th Annual Meeting of the Korean Society of Medical Oncology and the 2026 International Conference—will take place from 2–4 September 2026 at the Grand InterContinental Seoul Parnas in Seoul\, Korea. \nHeld in conjunction with the 14th International FACO Conference\, this year’s event centers on the theme “Advancing Cancer Care\, Restoring Hope and Lives.” Since its international expansion in 2019\, KSMO has evolved into a premier global hub for oncology professionals to exchange data on therapeutic innovations and multidisciplinary care strategies\, providing a vital platform for connecting clinical research with patient-centered outcomes in the Asia-Pacific region and beyond. \nRegister now.
URL:https://oncodaily.com/event/ksmo-2026-469574
LOCATION:Grand InterContinental Seoul Parnas\, 521 Teheran-ro\, Gangnam-gu\, Seoul\, 06164\, Korea\, Republic of
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/Annotation-2026-03-15-175542-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260902T183000
DTEND;TZID=America/Halifax:20260902T183000
DTSTAMP:20260721T141827Z
CREATED:20260721T141827Z
LAST-MODIFIED:20260721T141827Z
UID:10000808-1788373800-1788373800@oncodaily.com
SUMMARY:ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026
DESCRIPTION:The ESMO Deep Dive: First-Line Therapy for HRD-Negative Advanced Ovarian Cancer 2026 webinar\, organized by the European Society for Medical Oncology (ESMO)\, will take place live on 2 September 2026 at 18:30 CEST. \nThe session will examine the reliability of current HRD testing\, the role of PARP inhibitors in maintenance therapy\, and the emerging potential of antibody–drug conjugates for patients with HRD-negative advanced ovarian cancer. Faculty include Isabelle L. Ray-Coquard\, Charlie Gourley\, Robert Louis Coleman\, and Kathleen Nadine Moore. Registration is available exclusively to ESMO members\, and live participants will receive a certificate of attendance and two ESMO-MORA Category 1 points. \nRegister Now.
URL:https://oncodaily.com/event/ovarian-cancer-2026-547749
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/pxbee_2026-07-21_18-11-08.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260903
DTEND;VALUE=DATE:20260904
DTSTAMP:20260810T121818Z
CREATED:20260810T121818Z
LAST-MODIFIED:20260810T121818Z
UID:10000895-1788393600-1788479999@oncodaily.com
SUMMARY:The Pulmonology Conference BREATHE 2026
DESCRIPTION:The Pulmonology Conference BREATHE 2026\, organized by the Academia & Industria Forum\, is scheduled for 3 September 2026 and is listed in Sydney\, Australia. \nThe conference focuses on a broad range of pulmonary and respiratory medicine topics\, including respiratory infections\, COPD\, asthma\, chronic and rare lung diseases\, pediatric pulmonology\, lung transplantation\, thoracic surgery and imaging\, respiratory drug delivery\, tuberculosis\, and lung cancer and thoracic oncology. \nAccording to the event listing\, presentations are delivered through Zoom\, with access links provided to registered participants at the scheduled presentation time. Authors may register a presentation title and author names for inclusion in the programme\, while registered participants receive access to conference documents including a certificate\, ticket\, receipt\, and programme.
URL:https://oncodaily.com/event/pulmonology-conference-563361
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-10-2026-04_15_23-PM.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260903
DTEND;VALUE=DATE:20260905
DTSTAMP:20260728T135757Z
CREATED:20260728T135757Z
LAST-MODIFIED:20260728T135757Z
UID:10000838-1788393600-1788566399@oncodaily.com
SUMMARY:LeukO 2026: Global Virtual Congress on Leukemias
DESCRIPTION:The LeukO 2026 Global Virtual Congress on Leukemias\, organized by OncoDaily\, will take place online on 3–4 September 2026\, bringing together international experts for more than 40 scientific sessions on leukemia diagnosis\, treatment\, research\, and multidisciplinary care. \nLed scientifically by Marina Konopleva and Rami Komrokji\, the programme will cover molecular genetics\, risk stratification\, measurable residual disease\, artificial intelligence in diagnostics\, and current and emerging approaches across AML\, ALL\, CML\, CLL\, and rare leukemias. \nAdditional sessions will address targeted therapies\, CAR-T and bispecific antibodies\, transplantation\, relapse and treatment resistance\, supportive care\, fertility\, survivorship\, clinical-trial innovation\, and access to advanced treatment in resource-limited settings. The virtual congress is designed for clinicians\, researchers\, laboratory specialists\, nurses\, pharmacists\, trainees\, policymakers\, and patient advocates involved in leukemia care.
URL:https://oncodaily.com/event/553448
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/IMG_7439.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
LOCATION:
END:VEVENT
END:VCALENDAR